Jasper Therapeutics, Inc. (JSPR) announced that Herb Cross will resign from his roles as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, and Corporate Secretary to pursue other professional endeavors. The company has appointed existing executives to fill these roles on an interim basis.
Key Details
- Departing Executive: Herb Cross is resigning from his position as CFO and other principal officer roles.
- Effective Date: The resignation is effective October 9, 2026.
- Interim Appointments: Effective upon Mr. Cross's resignation, CEO Jeet Mahal will become interim Principal Financial Officer, VP of Finance Rick Ruiz will become interim Principal Accounting Officer, and COO Matthew Ros will become interim Corporate Secretary.